Israel Medical Innovation - Israeli-South African Trade, Technology ...
Israel Medical Innovation - Israeli-South African Trade, Technology ...
Israel Medical Innovation - Israeli-South African Trade, Technology ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Israel</strong> <strong>Medical</strong> <strong>Innovation</strong>2011<br />
Itamar <strong>Medical</strong><br />
www.itamar-medical.com<br />
Category:<br />
Diagnostics<br />
Cardiovascular and<br />
Peripheral Vascular<br />
General Health<br />
Neurology and<br />
Degenerative<br />
Diseases<br />
Respiratory and<br />
Pulmonary<br />
Company Status:<br />
Revenue Growth<br />
Company at a Glance<br />
Itamar <strong>Medical</strong> Ltd., is a public traded (TASE: ITMR) bio-medical technology company. Itamar<br />
develops and markets noninvasive diagnostic medical equipment based on proprietary<br />
PAT (Peripheral Arterial Tone) Signal. The PAT Signal serves as a noninvasive window<br />
to the Cardiovascular and Autonomic Nervous Systems.<br />
The PAT Signal is acquired by measuring pulsatile arterial volume changes in the fingertip<br />
by specialized noninvasive probes. Itamar’s FDA cleared and CE marked PAT-based<br />
products are:<br />
• Endo-PAT2000: noninvasive, office-based, user-independent device for endothelial<br />
function assessment – the precursor (earliest clinically detectable stage) of cardiovascular<br />
disease.<br />
• Watch-PAT200: ambulatory diagnosis of sleep related breathing disorders and sleep<br />
staging (Wake/REM/Deep sleep/light sleep stages).<br />
Both devices are used in preeminent clinical institutions, research centers and Pharmaceutical<br />
clinical phase studies in over 40 countries which have yielded nearly 300 publications.<br />
<strong>Technology</strong> and Product(s)<br />
Sleep testing - at home<br />
Considered “best in class”, WatchPAT (FDA cleared and CE marked) is a wrist mounted<br />
device for at-home testing of sleep apneas and sleep staging (REM/Deep Sleep/Light<br />
Sleep/Wake stages). WatchPAT also measures snoring and body position and provides a<br />
perfect combination of natural sleep at home with sleep-lab level data.<br />
WatchPAT works without the multiple cables and electrodes needed by other technologies<br />
which provide in-depth analysis of sleep, so it has an incredibly low failure rate. Yet the<br />
physician gets a comprehensive report with all the clinical parameters needed for patient<br />
treatment and monitoring. While the data is calculated automatically by the WatchPAT’s<br />
software, the physician can easily edit the data too.<br />
Noninvasive cardiovascular risk assessment<br />
Atherosclerosis is the clinical manifestation of endothelial dysfunction. Leading the field<br />
of endothelial function assessment, EndoPAT (FDA cleared and CE marked) is used in<br />
pre-eminent clinical institutions, research centers and Pharma studies. The noninvasive<br />
EndoPAT has been validated by nearly 100 publications and abstracts and provides<br />
clinicians with reliable and reproducible results in an office-based, 15 minute test.<br />
Goal<br />
Objectives: Establish wide distribution network in Europe<br />
Target Businesses: Distribution<br />
Target Countries: Brazil, Germany, UK, Spain, France, China, other<br />
Schedule a Meeting at<br />
Return to Table of Content<br />
39
Change language